Table 3. Vitamin D, Total Metastatic and Cancer Mortality Hazard Ratios and 95% Confidence Intervals by BMI Categories^a.

BMI category	Total No.	No. events in groups		Hazard ratio		P value for interaction
		Vitamin D	Placebo	HR (95% CI)	P value
Total metastatic cancer and cancer mortality (n = 25 254)
<25	7843	58	96	0.62 (0.45-0.86)	.004	.03
25 to <30	10 122	98	109	0.89 (0.68-1.17)	.42
≥30	7289	65	61	1.05 (0.74-1.49)	.79
Total metastatic cancer (n = 25 254)
<25	7843	24	39	0.63 (0.38-1.05)	.08	.21
25 to <30	10 122	37	46	0.80 (0.52-1.23)	.31
≥30	7289	25	24	1.03 (0.59-1.80)	.92
Cancer mortality (n = 25 254)
<25	7843	38	68	0.58 (0.39-0.86)	.007	.02
25 to <30	10 122	66	74	0.89 (0.64-1.23)	.472
≥30	7289	46	39	1.15 (0.75-1.76)	.518

Abbreviations: BMI, body mass index; HR, hazard ratio.

^aAnalyses were from Cox regression models that were controlled for age, sex, and omega-3 fatty acid randomization group. Analyses were not adjusted for multiple comparisons.